What is KHIDI’s role in supporting the development of the Korean health industry? KHIDI performs three major roles in supporting the Korean health industry, which includes…
In Conversation
Previous to your current position as President of Pfizer Korea since 2004, you had been in the country between 1989 and 1993 as sales and marketing…
APL is part of Zuellig, the top Asian pharmaceutical distributor. How does being part of a large, regionally specialized player help APL here in Indonesia? Being…
Please introduce Handok Pharmaceuticals to our readers, and in particular how it has evolved through partnerships with different multinational companies throughout its history. Handok has developed…
Korea had a late start, but is now one of the global hot spots for clinical trials. How would you sum up and explain this quick…
You have been in South Korea for several months, following some time as Merck’s President in Pakistan. In your opinion, what do you find as the…
What was the vision behind the creation of Neurotech back in 1998, originally as a Research Center, and then as an independent bio-tech company? It all…
Over the last several years we have seen a shift in clinical research from traditional healthcare markets to Asia. How do you see this trend evolving…
Since the installation of Mr. Fred Hassan in 2003, Schering-Plough has been oriented toward changes. At two years from your arrival you have been able to…
